WellGen

What WellGen does

WellGen is a privately held biotechnology company founded in 1997 and headquartered in North Brunswick, New Jersey. The company applies nutrigenomics — the study of interactions between plant-derived nutrients and genes — to discover and develop plant-based wellness products. Its headcount band of 11–50 employees and the nature of its work (small, discovery-oriented biotech) suggest a focused R&D and product-development operation rather than a large-scale commercial manufacturer.

Between 2001 and 2007 the company raised approximately $16.5 million across five funding rounds, with Amphion Innovations acting as lead investor on three rounds (2004, 2006, 2007) and Danisco Venture providing an initial investment in 2001. The trajectory of round sizes — from undisclosed in 2001, to $3M in 2004, $1M in 2005, $3M in 2006, and a $9.5M Series 3 in October 2007 — indicates progressive institutional support for the discovery pipeline. No funding events are recorded after 2007 in the supplied data. The co-founder is Geetha Ghai.

The firm's business model and go-to-market details (customer segments, distribution channels, pricing, contract structures, and current revenue) are not disclosed in the available data, which is a material limitation for commercial diligence. What is established is a small, North Brunswick–based biotech using a nutrigenomics discovery platform to generate plant-based wellness products, backed historically by a focused set of life-sciences venture investors.

Name

WellGen

Legal name

Infradapt, LLC

Website

https://wellgen.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

11–50 employees

Short description

WellGen is a privately held, North Brunswick, NJ–based biotechnology company founded in 1997 that uses nutrigenomics to discover and develop plant-based wellness products, historically backed by Amphion Innovations and Danisco Venture.

Ownership category

akta.pro rank

Product category

Nutrigenomics and Functional Food Ingredients

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Condition-Specific Bioactives (Glucosamine/Chondroitin, Plant Sterols, Melatonin, Lutein/Zeaxanthin) (AFAJAKAK)

akta.pro secondary industry

Specialty & Functional Packaged Foods (Gluten-Free, Keto, Organic, Medical/Allergen-Friendly) (CRADAAAI)

Keywords

• Nutrigenomics research
• Plant-based wellness
• Functional food ingredients
• Biotechnology development
• Natural health products

Headquarters

HQ city

North Brunswick

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Technology or R&D, Personnel, Operations

Revenue model

1. Managed IT Services Subscription: Predictable monthly technology costs with fixed fee covering IT management, cybersecurity monitoring, helpdesk support, vendor management, and proactive maintenance. Revenue derived from recurring monthly subscriptions with no surprise repair bills or random vendor invoices.
2. Business Communications Services: VoIP and hosted PBX services including HD voice, mobile and desktop softphones, unified messaging, and unlimited calling plans. Recurring subscription model for telecom services.
3. Private Hybrid Cloud Services: Cloud infrastructure services without capital investment requirements, quick provisioning, and elastic scaling. Recurring monthly billing for cloud resources and monitoring.
4. Cybersecurity and Compliance Services: Continuous monitoring, risk assessments, compliance documentation, staff training, and incident response services. Subscription-based security services.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

WellGen is a biotechnology company that applies nutrigenomics — the study of how food and plant compounds interact with genes — to discover and develop plant-based wellness products. The company focuses on leveraging plant-derived bioactives for human health applications, operating at the intersection of nutritional science and biotechnology R&D.

Product overview

Infradapt offers a unified managed IT services platform that integrates multiple technology solutions into a single partnership model. The core offering is Managed IT Services supported by specialized modules including Cybersecurity and Cyber Liability Protection, AI-Powered Surveillance, Business VoIP Solutions, Private Hybrid Cloud, Business Continuity and Disaster Recovery, and the Secure AI Suite. For small to medium-sized businesses, they offer an all-inclusive Outsourced IT package that bundles hardware, software, and services together. The company differentiates through a one-team, one-fee, one-ticket approach, combining managed IT, cybersecurity, business communications, private cloud, disaster recovery, and compliance-focused guidance into one strategic partnership.

Differentiator

Problem solved

Functional benefit

Named customers10 records

Segments6 records

Ideal customer profiles1 record

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature5 records

Scale indicators3 records

Recent moves6 records

Expansion highlights3 records

Emerging players

• Zoe: Zoe is an emerging personalized-nutrition company using blood, microbiome, and dietary data to deliver individualized wellness guidance. It is a relevant peer in the broader personalized-wellness category, though its primary focus is metabolic and microbiome science rather than pure nutrigenomics.
• AG1 (Athletic Greens): AG1 is an emerging plant-based daily wellness/nutrition brand with strong consumer traction and a science-forward positioning. It competes in the same end market of premium, plant-based wellness products and provides a useful benchmark for direct-to-consumer scale and brand-building potential.
• Ritual: Ritual is an emerging direct-to-consumer supplement brand built on science-backed, plant-based formulations and traceability. It is comparable to WellGen as a contemporary plant-based wellness brand targeting health-conscious consumers, though it does not employ a nutrigenomics discovery layer.

Direct peers

• DayTwo: DayTwo applies microbiome and metabolic science to deliver personalized nutrition recommendations and wellness products. It is a direct peer because it combines 'omics-based discovery' (parallel to nutrigenomics) with consumer-facing wellness offerings, competing for the same science-driven, personalized-wellness consumer.
• Pathway Genomics: Pathway Genomics offers genetic testing with wellness, nutrition, and lifestyle interpretation. It is a direct peer because it explicitly bridges consumer genomics and nutritional/wellness recommendations, occupying overlapping commercial territory with WellGen's nutrigenomics approach.
• Nutrigenomix: Nutrigenomix is a direct peer — it commercializes nutrigenomics testing and personalized nutrition recommendations, applying genetic science to dietary guidance. Like WellGen, it bridges genomics and nutrition/wellness, making its product strategy, customer segments (clinicians and consumers), and commercial validation directly comparable.

Broad incumbents

• Standard Process: Standard Process is an established whole-food, plant-based nutritional supplement manufacturer. It is a broad incumbent peer — operating in the same plant-based wellness category as WellGen, with a practitioner-channel GTM and full-line nutraceutical portfolio that contextualizes WellGen's addressable market.
• dsm-firmenich: dsm-firmenich is one of the world's largest nutrition and health ingredient companies, operating across vitamins, nutraceuticals, and functional food ingredients. It is a broad incumbent peer — relevant as both a potential acquirer/licensor of WellGen's discovery IP and as a benchmark for the B2B ingredient-supply economics WellGen could pursue.
• Herbalife: Herbalife is a broad incumbent in nutrition, wellness, and plant-based supplements. While not nutrigenomics-focused, it competes for the same end consumer of plant-based wellness products, with vastly greater scale, distribution, and marketing spend, providing a useful benchmark on go-to-market economics.
• BASF Nutrition & Health: BASF's Nutrition & Health division supplies vitamins, carotenoids, and functional ingredients to the nutraceutical and food industries. It is a broad incumbent peer because it competes in the same plant-based functional ingredient category and represents a likely strategic counterpart for ingredient licensing or M&A.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

• Xx.com/infradapt
• Facebookfacebook.com/infradapt

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds5 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about WellGen